Haleon plc
Haleon plc HLNCF Peers
See (HLNCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HLNCF | $5.10 | -4.67% | 46.01B | 24.29 | $0.21 | +2.05% |
| MKKGY | $28.44 | +2.01% | 61.69B | 19.61 | $1.45 | +1.34% |
| MKGAF | $137.80 | -3.06% | 59.91B | 19.09 | $7.22 | +1.63% |
| TKPHF | $28.90 | +3.44% | 45.48B | 32.11 | $0.90 | +4.60% |
| IPSEY | $29.20 | +4.17% | 38.64B | 24.13 | $1.21 | +1.08% |
| SDZNY | $45.05 | +0.42% | 19.40B | -2252.50 | -$0.02 | +0.91% |
| TEVJF | $16.11 | -9.49% | 18.46B | -14.01 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOY | $8.49 | +2.41% | 14.44B | 12.48 | $0.68 | +0.94% |
| SGIOF | $15.20 | N/A | 12.93B | 10.94 | $1.39 | +2.74% |
Stock Comparison
HLNCF vs MKKGY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, MKKGY has a market cap of 61.69B. Regarding current trading prices, HLNCF is priced at $5.10, while MKKGY trades at $28.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas MKKGY's P/E ratio is 19.61. In terms of profitability, HLNCF's ROE is +0.09%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, HLNCF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs MKGAF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, MKGAF has a market cap of 59.91B. Regarding current trading prices, HLNCF is priced at $5.10, while MKGAF trades at $137.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas MKGAF's P/E ratio is 19.09. In terms of profitability, HLNCF's ROE is +0.09%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, HLNCF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TKPHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TKPHF has a market cap of 45.48B. Regarding current trading prices, HLNCF is priced at $5.10, while TKPHF trades at $28.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TKPHF's P/E ratio is 32.11. In terms of profitability, HLNCF's ROE is +0.09%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs IPSEY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, IPSEY has a market cap of 38.64B. Regarding current trading prices, HLNCF is priced at $5.10, while IPSEY trades at $29.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas IPSEY's P/E ratio is 24.13. In terms of profitability, HLNCF's ROE is +0.09%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, HLNCF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SDZNY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SDZNY has a market cap of 19.40B. Regarding current trading prices, HLNCF is priced at $5.10, while SDZNY trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SDZNY's P/E ratio is -2252.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TEVJF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, HLNCF is priced at $5.10, while TEVJF trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, HLNCF's ROE is +0.09%, compared to TEVJF's ROE of -0.26%. Regarding short-term risk, HLNCF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ESALY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, HLNCF is priced at $5.10, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HLNCF's ROE is +0.09%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HLNCF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SGIOY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SGIOY has a market cap of 14.44B. Regarding current trading prices, HLNCF is priced at $5.10, while SGIOY trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SGIOY's P/E ratio is 12.48. In terms of profitability, HLNCF's ROE is +0.09%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, HLNCF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SGIOF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, HLNCF is priced at $5.10, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SGIOF's P/E ratio is 10.94. In terms of profitability, HLNCF's ROE is +0.09%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, HLNCF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs BIOVF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, HLNCF is priced at $5.10, while BIOVF trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas BIOVF's P/E ratio is 25.85. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, HLNCF is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs IPSEF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, HLNCF is priced at $5.10, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas IPSEF's P/E ratio is 25.96. In terms of profitability, HLNCF's ROE is +0.09%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, HLNCF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SFOSF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SFOSF has a market cap of 8.62B. Regarding current trading prices, HLNCF is priced at $5.10, while SFOSF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SFOSF's P/E ratio is 12.97. In terms of profitability, HLNCF's ROE is +0.09%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, HLNCF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ESAIY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ESAIY has a market cap of 7.67B. Regarding current trading prices, HLNCF is priced at $5.10, while ESAIY trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ESAIY's P/E ratio is 18.72. In terms of profitability, HLNCF's ROE is +0.09%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, HLNCF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ESALF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ESALF has a market cap of 7.05B. Regarding current trading prices, HLNCF is priced at $5.10, while ESALF trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ESALF's P/E ratio is 17.36. In terms of profitability, HLNCF's ROE is +0.09%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, HLNCF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GZPHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GZPHF has a market cap of 6.27B. Regarding current trading prices, HLNCF is priced at $5.10, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, HLNCF's ROE is +0.09%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, HLNCF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HKMPF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HKMPF has a market cap of 5.94B. Regarding current trading prices, HLNCF is priced at $5.10, while HKMPF trades at $26.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HKMPF's P/E ratio is 16.73. In terms of profitability, HLNCF's ROE is +0.09%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, HLNCF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HKMPY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HKMPY has a market cap of 5.93B. Regarding current trading prices, HLNCF is priced at $5.10, while HKMPY trades at $53.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HKMPY's P/E ratio is 16.70. In terms of profitability, HLNCF's ROE is +0.09%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, HLNCF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs APNHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, HLNCF is priced at $5.10, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas APNHF's P/E ratio is 20.07. In terms of profitability, HLNCF's ROE is +0.09%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, HLNCF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs WIBFF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, WIBFF has a market cap of 4.92B. Regarding current trading prices, HLNCF is priced at $5.10, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, HLNCF's ROE is +0.09%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, HLNCF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LVZPF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LVZPF has a market cap of 4.06B. Regarding current trading prices, HLNCF is priced at $5.10, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, HLNCF's ROE is +0.09%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, HLNCF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HLBBF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HLBBF has a market cap of 4.04B. Regarding current trading prices, HLNCF is priced at $5.10, while HLBBF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HLBBF's P/E ratio is 10.62. In terms of profitability, HLNCF's ROE is +0.09%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, HLNCF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HLUBF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HLUBF has a market cap of 3.37B. Regarding current trading prices, HLNCF is priced at $5.10, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, HLNCF's ROE is +0.09%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, HLNCF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs APNHY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, APNHY has a market cap of 3.05B. Regarding current trading prices, HLNCF is priced at $5.10, while APNHY trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas APNHY's P/E ratio is 12.47. In terms of profitability, HLNCF's ROE is +0.09%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs INVVY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, HLNCF is priced at $5.10, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HLNCF's ROE is +0.09%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, HLNCF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs IZQVF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, HLNCF is priced at $5.10, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HLNCF's ROE is +0.09%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, HLNCF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HMDCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, HLNCF is priced at $5.10, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, HLNCF's ROE is +0.09%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, HLNCF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs DNPUF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, HLNCF is priced at $5.10, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas DNPUF's P/E ratio is -2.12. In terms of profitability, HLNCF's ROE is +0.09%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, HLNCF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ULIHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, HLNCF is priced at $5.10, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, HLNCF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HYPMY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HYPMY has a market cap of 2.51B. Regarding current trading prices, HLNCF is priced at $5.10, while HYPMY trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HYPMY's P/E ratio is 18.05. In terms of profitability, HLNCF's ROE is +0.09%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, HLNCF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HTSUF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, HLNCF is priced at $5.10, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HTSUF's P/E ratio is 15.68. In terms of profitability, HLNCF's ROE is +0.09%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs THCBF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, THCBF has a market cap of 2.34B. Regarding current trading prices, HLNCF is priced at $5.10, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas THCBF's P/E ratio is -0.10. In terms of profitability, HLNCF's ROE is +0.09%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, HLNCF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CHSYF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, HLNCF is priced at $5.10, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, HLNCF's ROE is +0.09%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, HLNCF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TSMRF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, HLNCF is priced at $5.10, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, HLNCF's ROE is +0.09%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, HLNCF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs DMPHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, HLNCF is priced at $5.10, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas DMPHF's P/E ratio is 16.55. In terms of profitability, HLNCF's ROE is +0.09%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, HLNCF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LJUIF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, HLNCF is priced at $5.10, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, HLNCF's ROE is +0.09%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, HLNCF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LBTSF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, HLNCF is priced at $5.10, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, HLNCF's ROE is +0.09%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, HLNCF is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs NPNKF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, NPNKF has a market cap of 1.77B. Regarding current trading prices, HLNCF is priced at $5.10, while NPNKF trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas NPNKF's P/E ratio is 8.35. In terms of profitability, HLNCF's ROE is +0.09%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, HLNCF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SHEZF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SHEZF has a market cap of 1.69B. Regarding current trading prices, HLNCF is priced at $5.10, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, HLNCF's ROE is +0.09%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, HLNCF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CHIZF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, HLNCF is priced at $5.10, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, HLNCF's ROE is +0.09%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, HLNCF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SMDPY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, HLNCF is priced at $5.10, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SMDPY's P/E ratio is -1.32. In terms of profitability, HLNCF's ROE is +0.09%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, HLNCF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs AUSAF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, AUSAF has a market cap of 1.57B. Regarding current trading prices, HLNCF is priced at $5.10, while AUSAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas AUSAF's P/E ratio is N/A. In terms of profitability, HLNCF's ROE is +0.09%, compared to AUSAF's ROE of -1.15%. Regarding short-term risk, HLNCF is less volatile compared to AUSAF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs NPPNY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, NPPNY has a market cap of 1.57B. Regarding current trading prices, HLNCF is priced at $5.10, while NPPNY trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas NPPNY's P/E ratio is 7.35. In terms of profitability, HLNCF's ROE is +0.09%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, HLNCF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs KARBF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, HLNCF is priced at $5.10, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to KARBF's ROE of N/A. Regarding short-term risk, HLNCF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs YIHCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, YIHCF has a market cap of 1.47B. Regarding current trading prices, HLNCF is priced at $5.10, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, HLNCF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs EVOTF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, HLNCF is priced at $5.10, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, HLNCF's ROE is +0.09%, compared to EVOTF's ROE of -0.19%. Regarding short-term risk, HLNCF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ARSUF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, HLNCF is priced at $5.10, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, HLNCF's ROE is +0.09%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, HLNCF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GTBIF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GTBIF has a market cap of 1.31B. Regarding current trading prices, HLNCF is priced at $5.10, while GTBIF trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GTBIF's P/E ratio is 18.36. In terms of profitability, HLNCF's ROE is +0.09%, compared to GTBIF's ROE of +0.04%. Regarding short-term risk, HLNCF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SWGHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SWGHF has a market cap of 1.15B. Regarding current trading prices, HLNCF is priced at $5.10, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SWGHF's P/E ratio is 13.71. In terms of profitability, HLNCF's ROE is +0.09%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, HLNCF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs BIOGY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, BIOGY has a market cap of 1.12B. Regarding current trading prices, HLNCF is priced at $5.10, while BIOGY trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas BIOGY's P/E ratio is 33.78. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOGY's ROE of +0.20%. Regarding short-term risk, HLNCF is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GNMLF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, HLNCF is priced at $5.10, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, HLNCF's ROE is +0.09%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, HLNCF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs NIKA Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, NIKA has a market cap of 1.03B. Regarding current trading prices, HLNCF is priced at $5.10, while NIKA trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas NIKA's P/E ratio is N/A. In terms of profitability, HLNCF's ROE is +0.09%, compared to NIKA's ROE of +0.63%. Regarding short-term risk, HLNCF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs KKPCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, KKPCF has a market cap of 1.01B. Regarding current trading prices, HLNCF is priced at $5.10, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas KKPCF's P/E ratio is 7.10. In terms of profitability, HLNCF's ROE is +0.09%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, HLNCF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs KSPHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, HLNCF is priced at $5.10, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas KSPHF's P/E ratio is 12.16. In terms of profitability, HLNCF's ROE is +0.09%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CASBF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CASBF has a market cap of 984.67M. Regarding current trading prices, HLNCF is priced at $5.10, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CASBF's P/E ratio is -15.24. In terms of profitability, HLNCF's ROE is +0.09%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, HLNCF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LVTTF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LVTTF has a market cap of 880.16M. Regarding current trading prices, HLNCF is priced at $5.10, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, HLNCF's ROE is +0.09%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, HLNCF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs EVRRF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, EVRRF has a market cap of 873.78M. Regarding current trading prices, HLNCF is priced at $5.10, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, HLNCF's ROE is +0.09%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, HLNCF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TCNNF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TCNNF has a market cap of 857.99M. Regarding current trading prices, HLNCF is priced at $5.10, while TCNNF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TCNNF's P/E ratio is -5.67. In terms of profitability, HLNCF's ROE is +0.09%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, HLNCF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs NRXCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, NRXCF has a market cap of 829.09M. Regarding current trading prices, HLNCF is priced at $5.10, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, HLNCF's ROE is +0.09%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, HLNCF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TWAPF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, HLNCF is priced at $5.10, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TWAPF's P/E ratio is 6.16. In terms of profitability, HLNCF's ROE is +0.09%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, HLNCF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CSWYF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, HLNCF is priced at $5.10, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, HLNCF's ROE is +0.09%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, HLNCF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TRXPF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, HLNCF is priced at $5.10, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HLNCF's ROE is +0.09%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, HLNCF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SWDCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, HLNCF is priced at $5.10, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, HLNCF's ROE is +0.09%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HLNCF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CURLF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CURLF has a market cap of 653.58M. Regarding current trading prices, HLNCF is priced at $5.10, while CURLF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CURLF's P/E ratio is -2.79. In terms of profitability, HLNCF's ROE is +0.09%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, HLNCF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs TRSSF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, HLNCF is priced at $5.10, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HLNCF's ROE is +0.09%, compared to TRSSF's ROE of -0.43%. Regarding short-term risk, HLNCF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SGFEF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SGFEF has a market cap of 544.13M. Regarding current trading prices, HLNCF is priced at $5.10, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SGFEF's P/E ratio is 22.83. In terms of profitability, HLNCF's ROE is +0.09%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, HLNCF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CCHWF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, HLNCF is priced at $5.10, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HLNCF's ROE is +0.09%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, HLNCF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs AIHLF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, HLNCF is priced at $5.10, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, HLNCF's ROE is +0.09%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HLNCF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs BOIRF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, HLNCF is priced at $5.10, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, HLNCF's ROE is +0.09%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, HLNCF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs PEXXF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, HLNCF is priced at $5.10, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HLNCF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ELTP Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ELTP has a market cap of 459.36M. Regarding current trading prices, HLNCF is priced at $5.10, while ELTP trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ELTP's P/E ratio is -21.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, HLNCF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs SHPHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, SHPHF has a market cap of 455.30M. Regarding current trading prices, HLNCF is priced at $5.10, while SHPHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas SHPHF's P/E ratio is -1.64. In terms of profitability, HLNCF's ROE is +0.09%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, HLNCF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs MITPF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, HLNCF is priced at $5.10, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas MITPF's P/E ratio is -3.05. In terms of profitability, HLNCF's ROE is +0.09%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, HLNCF is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs KHTRF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, KHTRF has a market cap of 443.54M. Regarding current trading prices, HLNCF is priced at $5.10, while KHTRF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas KHTRF's P/E ratio is 148.67. In terms of profitability, HLNCF's ROE is +0.09%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, HLNCF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs AGYTF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, HLNCF is priced at $5.10, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, HLNCF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GLASF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GLASF has a market cap of 314.01M. Regarding current trading prices, HLNCF is priced at $5.10, while GLASF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GLASF's P/E ratio is -30.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, HLNCF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs PKBFF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, PKBFF has a market cap of 288.49M. Regarding current trading prices, HLNCF is priced at $5.10, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HLNCF is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs BHCCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, HLNCF is priced at $5.10, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HLNCF's ROE is +0.09%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, HLNCF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs VRNOF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, VRNOF has a market cap of 259.00M. Regarding current trading prices, HLNCF is priced at $5.10, while VRNOF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas VRNOF's P/E ratio is -0.73. In terms of profitability, HLNCF's ROE is +0.09%, compared to VRNOF's ROE of -0.24%. Regarding short-term risk, HLNCF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CRLBF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CRLBF has a market cap of 240.87M. Regarding current trading prices, HLNCF is priced at $5.10, while CRLBF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CRLBF's P/E ratio is -3.25. In terms of profitability, HLNCF's ROE is +0.09%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, HLNCF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CPHRF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CPHRF has a market cap of 237.44M. Regarding current trading prices, HLNCF is priced at $5.10, while CPHRF trades at $9.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CPHRF's P/E ratio is 20.15. In terms of profitability, HLNCF's ROE is +0.09%, compared to CPHRF's ROE of +0.12%. Regarding short-term risk, HLNCF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs PLNHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, HLNCF is priced at $5.10, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HLNCF's ROE is +0.09%, compared to PLNHF's ROE of +0.01%. Regarding short-term risk, HLNCF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HUMDF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, HLNCF is priced at $5.10, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, HLNCF's ROE is +0.09%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, HLNCF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs COPHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, HLNCF is priced at $5.10, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HLNCF's ROE is +0.09%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HLNCF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs PHCUF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, PHCUF has a market cap of 117.10M. Regarding current trading prices, HLNCF is priced at $5.10, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas PHCUF's P/E ratio is -432.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, HLNCF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LPCUF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, HLNCF is priced at $5.10, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, HLNCF's ROE is +0.09%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, HLNCF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CNVCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, HLNCF is priced at $5.10, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, HLNCF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GRUSF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GRUSF has a market cap of 107.69M. Regarding current trading prices, HLNCF is priced at $5.10, while GRUSF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GRUSF's P/E ratio is -8.69. In terms of profitability, HLNCF's ROE is +0.09%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, HLNCF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs HLTRF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, HLNCF is priced at $5.10, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas HLTRF's P/E ratio is -5.19. In terms of profitability, HLNCF's ROE is +0.09%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, HLNCF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs ABSCF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, HLNCF is priced at $5.10, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas ABSCF's P/E ratio is -20.00. In terms of profitability, HLNCF's ROE is +0.09%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, HLNCF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs PLNH Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, PLNH has a market cap of 88.93M. Regarding current trading prices, HLNCF is priced at $5.10, while PLNH trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas PLNH's P/E ratio is -1.71. In terms of profitability, HLNCF's ROE is +0.09%, compared to PLNH's ROE of -0.36%. Regarding short-term risk, HLNCF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs BIOYF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, BIOYF has a market cap of 88.33M. Regarding current trading prices, HLNCF is priced at $5.10, while BIOYF trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas BIOYF's P/E ratio is 17.11. In terms of profitability, HLNCF's ROE is +0.09%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, HLNCF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LOVFF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LOVFF has a market cap of 84.71M. Regarding current trading prices, HLNCF is priced at $5.10, while LOVFF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LOVFF's P/E ratio is 9.34. In terms of profitability, HLNCF's ROE is +0.09%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, HLNCF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GBLP Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, HLNCF is priced at $5.10, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GBLP's P/E ratio is -0.67. In terms of profitability, HLNCF's ROE is +0.09%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, HLNCF is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs LRDSF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, LRDSF has a market cap of 82.83M. Regarding current trading prices, HLNCF is priced at $5.10, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, HLNCF's ROE is +0.09%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, HLNCF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs CBWTF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, CBWTF has a market cap of 80.69M. Regarding current trading prices, HLNCF is priced at $5.10, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas CBWTF's P/E ratio is -6.14. In terms of profitability, HLNCF's ROE is +0.09%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, HLNCF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs EOFBY Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, HLNCF is priced at $5.10, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, HLNCF's ROE is +0.09%, compared to EOFBY's ROE of N/A. Regarding short-term risk, HLNCF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs AAWH Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, AAWH has a market cap of 70.80M. Regarding current trading prices, HLNCF is priced at $5.10, while AAWH trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas AAWH's P/E ratio is -0.86. In terms of profitability, HLNCF's ROE is +0.09%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, HLNCF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs JUSHF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, JUSHF has a market cap of 67.57M. Regarding current trading prices, HLNCF is priced at $5.10, while JUSHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas JUSHF's P/E ratio is -1.37. In terms of profitability, HLNCF's ROE is +0.09%, compared to JUSHF's ROE of +1.44%. Regarding short-term risk, HLNCF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.
HLNCF vs GDNSF Comparison
HLNCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLNCF stands at 46.01B. In comparison, GDNSF has a market cap of 61.05M. Regarding current trading prices, HLNCF is priced at $5.10, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLNCF currently has a P/E ratio of 24.29, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, HLNCF's ROE is +0.09%, compared to GDNSF's ROE of -1.54%. Regarding short-term risk, HLNCF is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLNCF.